Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001104659-16-156969
Filing Date
2016-11-14
Accepted
2016-11-14 17:17:51
Documents
1
Period of Report
2016-09-30
Effectiveness Date
2016-11-14

Document Format Files

Seq Description Document Type Size
1 NT 10-Q a16-21622_1nt10q.htm NT 10-Q 56490
  Complete submission text file 0001104659-16-156969.txt   57534
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

EIN.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-32966 | Film No.: 161995941
SIC: 2836 Biological Products, (No Diagnostic Substances)